Inhibitory effect of a new butadiene derivative on the production of plasminogen activator inhibitor-1 in cultured bovine endothelial cells

Journal of Biochemistry

Volumn 120, Issue 6, 1996, Pages 1203-1208

  Ohtani, Akio ^a   Takagi, Tamotsu ^a   Hirano, Ayako ^a   Murakami, Jun ^a   Sasaki, Yasuhiko ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Endothelial cell; Fibrinolysis; Plasminogen activator; Plasminogen activator inhibitor 1; T 686

Indexed keywords

1,3 BUTADIENE DERIVATIVE; 3 BENZYLIDENE 4 (3,4,5 TRIMETHOXYBENZYLIDENE) PYRROLIDINE 2,5 DIONE; 3 BENZYLIDENE 4 (3,4,5 TRIMETHOXYBENZYLIDENE)SUCCINIMIDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; FIBRINOLYSIS; NONHUMAN; NORTHERN BLOTTING; PROTEIN SYNTHESIS; RAT; VASCULAR ENDOTHELIUM;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0030479039     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a021542     Document Type: Article

References (37)

1. Sprengers, E.D. and Kluft, C. (1987) Plasminogen activator inhibitors. Blood 69, 381-387
2. Schneiderman, J. and Loskutoff, D.J. (1991) Plasminogen activator inhibitors. Trends Cardiovasc. Med. 1, 99-102
3. Dawson, S. and Henney, A. (1992) The Status of PAI-1 as a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 95, 105-117
4. Schleef, R.R., Higgins, D.L., Pillemer, E., and Levitt, L.J. (1989) Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J. Clin. Invest. 83, 1747-1752
5. Dieval, J., Nguyen, G., Gross, S., Delobel, J., and Kruithof, E.K.O. (1991) A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood 77, 528-532
6. Nilsson, I.M., Ljungner, H., and Tengborn, L. (1985) Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br. Med. J. 290, 1453-1456
7. Wiman, B., Ljungberg, B., Chmielewska, J., Urden, G., Blomback, M., and Johnsson, H. (1985) The role of the fibrinolytic system in deep vein thrombosis. J. Lab. Clin. Med. 105, 265-270
8. Juhan-Vague, I., Valadier, J., Alessi, M.C., Aillaud, M.F., Ansaldi, J., Philip-Joet, C., Holvoet, P., Serradimigni, A., and Collen, D. (1987) Deficient t-PA release elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb. Haemost. 57, 67-72
9. Hamsten, A., Wiman, B., De Faire, U., and Blomback, M. (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313, 1557-1563
10. Aimer, L.O. and Ohlin, H. (1987) Elevated levels of the rapid inhibitor of plasminogen activator (t-PA) in acute myocardial infarction. Thromb. Res. 47, 335-339
11. Sakata, K., Kurata, C., Kobayashi, A., Rydzewski, A., and Yamazaki, N. (1991) Plasminogen activator inhibitor activity as a possible indicator of disease activity in rest angina with angiographically insignificant coronary artery stenosis. Thromb. Res. 63, 491-502
12. Kooistra, T. (1990) The use of cultured human endothelial cells and hepatocytes as an in vitro model system to study modulation of endogenous fibrinolysis. Fibrinolysis 4, 33-39
13. Levin, E.G., Marzec, U., Anderson, J., and Harker, L.A. (1984) Thrombin stimulates tissue plasminogen activator release from human cultured endothelial cells. J. Clin. Invest. 74, 1988-1995
14. Van Hinsberg, VWM., Sprengers, E.D., and Kooistra, T. (1987) Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb. Haemost. 57, 148-153
15. Kooistra, T., Van Den Berg, J., Tons, A., Platenburg, G., Rijken, D.C., and Van Den Berg, E. (1987) Butyrate stimulates tissue-type plasminogen activator synthesis in cultured human endothelial cells. Biochem. J. 247, 605-612
16. Bulens, F., Nelles, L., Van Den Panhuyzen, N., and Collen, D. (1992) Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: Relations of structure to effect. J. Cardiovasc. Pharmacol. 19, 508-514
17. Kojima, S., Hagiwara, H., Shimonaka, M., Saito, Y., and Inada, Y. (1986) Synergism of retinoids and L-ascorbic acid in producing plasminogen activator in endothelial cells. Biomed. Res. 7, 155-159
18. Bevilacqua, M.P., Schleef, R.R., Gimbrone, M.A., Jr., and Loskutoff, D.J. (1986) Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin-1. J. Clin. Invest. 78, 578-591
19. Schleef, R.R., Bevilacqua, M.P., Sawdey, M., Gimbrone, M.A., Jr., and Loskutoff, D.J. (1988) Cytokine activation of vascular endothelium: Effects on tissue type plasminogen activator and type-1 plasminogen activator inhibitor. J. Biol. Chem. 263, 5797-5803
20. Sawdey, M., Podor, T.J., and Loskutoff, D.J. (1989) Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: Induction by transforming growth factor-β, lipopolysaccharide, and tumor necrosis factor-α. J. Biol. Chem. 264, 10396-10401
21. Fujii, S., Hopkins, W.E., and Sobel, B.E. (1991) Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type-1 in endothelial cells by constituents of platelets and their implications for thrombolysis. Circulation 83, 645-651
22. Fujii, S. and Sobel, B.E. (1992) Direct effects of gemfibrozil on the fibrinolytic system: Diminution of synthesis of plasminogen activator inhibitor type 1. Circulation 85, 1888-1893
23. Fujii, S., Sawa, H., and Sobel, B.E. (1993) Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil. Thromb. Haemost. 70, 642-647
24. Gospodarowicz, D., Moran, J., Braun, D., and Birdwell, C. (1976) Clonal growth of bovine vascular endothelial cells: Fibroblast growth factor as a survival agent. Proc. Natl. Acad. Sci. USA 73, 4120-4124
25. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
26. Loskutoff, D.J., van Mourik, J.A., and Lawrence, D. (1983) Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc. Natl. Acad. Sci. USA 80, 2956-2960
27. Zeheb, E. and Gelehrter, T.D. (1988) Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 73, 459-468
28. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 62, 156-159
29. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1982) Molecular Cloning. A Laboratory Manual, 7.40-7.42, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
30. Chmielewska, J. and Wiman, B. (1986) Determination of tissue plasminogen activator and its "fast" inhibitor in plasma. Clin. Chem. 32, 482-485
31. Kojima, S., Inui, T., Kimura, T., Sakakibara, S., Muramatsu, H., Amanuma, H., Maruta, H., and Muramatsu, T. (1995) Synthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells. Biochem. Biophys. Res. Commun. 206, 468-473
32. Noda-Heiny, H., Fujii, S., and Sobel, B.E. (1993) Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin. Circ. Res. 72, 36-43
33. Sakata, Y., Okada, M., Noro, A., and Matsuda, M. (1988) Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor-1 on the surface of endothelial cells. J. Biol. Chem. 263, 1960-1969
34. Erickson, L.A., Fici, G.J., Lund, J.E., Boyle, T.P., Polites, H.G., and Marotti, K.R. (1990) Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature 34, 74-76
35. Carmeliet, P., Stassen, J.M., Schoonjans, L., Ream, B., van den Oord, J.J., De Mol, M., Mulligan, R.C., and Collen, D. (1993) Plasminogen activator inhibitor-1 gene-deficient mice: II. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92, 2756-2760
36. Slivka, S.R. and Loskutoff, D.J. (1991) Regulation of type I plasminogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells. Biochim. Biophys. Acta 1094, 317-322
37. Levin, E.G., Marotti, K.R., and Santell, L. (1989) Protein kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells. Dependence on the elevation of messenger RNA. J. Biol. Chem. 264, 16030-16036